IRON Disc Medicine, Inc.
Healthcare$67.69+0.00%OpenMarket Cap: $2.59B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.74
P/S
0.00
EV/EBITDA
-10.21
DCF Value
$2.31
FCF Yield
-7.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-36.9%
ROA
-32.2%
ROIC
-36.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-69.5M | $-63.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-67.0M | $-60.5M | $— | — |
| FY null | $0.00 | NaN% | $-236.0M | $-212.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-67.7M | $-62.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-61.4M | $-55.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-39.9M | $-34.1M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-34.5M | $-29.5M | $— | — |
| FY null | $0.00 | NaN% | $-129.7M | $-109.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-32.9M | $-26.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-30.9M | $-26.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-31.5M | $-26.9M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-29.7M | $-23.6M | $-1.00 | — |